Exchange: NASDAQ·Updated 07:30 PM EST
ANTX logo

ANTX AN2 Therapeutics Inc

$5.08
$0.14
(2.68%)
Today
Closed $5.08
$0.00
(0.00%)
After Hours
Reported EarningsNov 9
Mkt Cap$192.75M
Vol332,714.00

About ANTX

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley in 2017 and is headquartered in Menlo Park, CA.
61

Bullish Sentiment

How do you feel about ANTX?

Advertisement|Remove ads.